Development and Evaluation of Co-Amorphous Raloxifene Formulation for Transdermal Delivery.

Documents similaires

• Formulation and Evaluation of Transdermal Isoniazid Cubosomes
  par: Tarwala Yash
• Development and Evaluation of Raloxifene Nanosuspension for Bioavailability Enhancement
  par: Mohale Samyak
• Formulation Development and Evaluation of Brinzolamide for Ocular Delivery
  par: Suryawanshi Gaurav
• Intranasal Nanoparticle Based Delivery of Telmisartan for Brain Targeting : Formulation Development and Invivo Evaluation
  par: Ganti Srikar
• Formulation and Evaluation of Galatamine Nanoparticles
  par: Datta Abhishek